dc.contributor.author | Alvear Sedán, Ciro | spa |
dc.contributor.author | Barboza Ubarnes, Miriam | spa |
dc.contributor.author | Stave Salgado, Karen | spa |
dc.date.accessioned | 2013-07-15 00:00:00 | |
dc.date.available | 2013-07-15 00:00:00 | |
dc.date.issued | 2013-07-15 | |
dc.identifier.issn | 2215-7840 | |
dc.identifier.uri | https://hdl.handle.net/11227/13004 | |
dc.format.mimetype | application/pdf | spa |
dc.language.iso | spa | spa |
dc.publisher | Universidad de Cartagena | spa |
dc.relation.ispartofjournal | Revista Ciencias Biomédicas | spa |
dc.rights | Revista Ciencias Biomédicas - 2020 | spa |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-sa/4.0/ | spa |
dc.source | https://revistas.unicartagena.edu.co/index.php/cbiomedicas/article/view/2833 | spa |
dc.subject | Fenilcetonuria | spa |
dc.subject | Fenilalanina | spa |
dc.subject | Mutación | spa |
dc.subject | Fenilalanina hidroxilasa | spa |
dc.subject | Trastornos neurológicos. | spa |
dc.title | Trastornos neurológicos a consecuencia de la mutación del gen que codifica para fenilalanina hidroxilasa | spa |
dc.type | Artículo de revista | spa |
dc.title.translated | Trastornos neurológicos a consecuencia de la mutación del gen que codifica para fenilalanina hidroxilasa | eng |
dc.identifier.doi | 10.32997/rcb-2013-2833 | |
dc.type.version | info:eu-repo/semantics/publishedVersion | spa |
dc.type.coarversion | http://purl.org/coar/version/c_970fb48d4fbd8a85 | spa |
dc.rights.coar | http://purl.org/coar/access_right/c_abf2 | spa |
dc.identifier.eissn | 2389-7252 | |
dc.identifier.url | https://doi.org/10.32997/rcb-2013-2833 | |
dc.relation.bitstream | https://revistas.unicartagena.edu.co/index.php/cbiomedicas/article/download/2833/2378 | |
dc.relation.citationedition | Núm. 2 , Año 2013 | spa |
dc.relation.citationendpage | 344 | |
dc.relation.citationissue | 2 | spa |
dc.relation.citationstartpage | 339 | |
dc.relation.citationvolume | 4 | spa |
dc.relation.references | Coll M.J, Ribes A. Aportación de la genética molecular a los trastornos neurometabólicos hereditarios. Rev Neurol. 2002;35(2):149-153. | spa |
dc.relation.references | Fernández I, Tellería JJ, Alonso M, Palencia R, Durán M, López B, et al. Enfermedades autosómicas recesivas con retraso mental. Rev Neurol. 2006;42(Supl-1):S39-S43. | spa |
dc.relation.references | Blau N, van Spronsen FJ, Levy H. Phenylketonuria. Lancet. 2010; 376(9750):1417-1427. | spa |
dc.relation.references | De Groot MJ, Hoeksma M, Blau N, Reijngoud DJ, van Spronsen FJ. Pathogenesis of cognitive dysfunction in phenylketonuria: Review of hypotheses. Mol Genet Metab. 2010;99:S86-S89. | spa |
dc.relation.references | Blau N, Hennermann JB, Langenbeck U, Lichter-Konecki U. Diagnosis, classification, and genetics of phenylketonuria and tetrahydrobiopterin (BH4) deficiencies. Mol Genet Metab. 2011;104:S2-S9. | spa |
dc.relation.references | Osmo G, Westphal I. Feferbaum R. Fenilcetonuria da restricao dietética a inclusao socioeconomic. Rev Bras Nutr Clin. 2008;23(2):104-10. | spa |
dc.relation.references | Gersting S, Kemter F, Staudigl M, Dunja D, Messing DD, Danecka MK, Florian B, Lagler FB,et al. Loss of Function in Phenylketonuria Is Caused by Impaired Molecular Motions and Conformational Instability. A J HG. 2008;83(1):5-17. | spa |
dc.relation.references | Scriver CH. The PAH Gene, Phenylketonuria and A Paradigm Shift. Hum Mutat. 2007;28(9):831-845. | spa |
dc.relation.references | Pelloc JM, Hrachovy R, Shinnar S,Borana TZ,Bettis D, Dlugas DJ, et al. Infantile spasms:a US consensus report .Epilepsia. 2010;51(10):2175-2189. | spa |
dc.relation.references | Hoeksma M, Reijngoud DJ, Pruim J, de Valk H, Panns A, van Spronsen FJ. Phenylketonuria: High plasma phenylalanine decreases cerebral protein synthesis. Mol Genet Metab. 2009;96(4):177-182. | spa |
dc.relation.references | Demirkol M, Giżewska M, Giovannini M, Walter J. Follow up of phenylketonuria patients. Mol Genet Metab. 2011;104:S31–S39. | spa |
dc.relation.references | Trefz FK, Belanger-Quintana A. Sapropterin dihydrochloride: a new drug and a new concept in the management of phenylketonuria. Drugs Today. 2010; 46(8):589-600. | spa |
dc.relation.references | Acosta P, Michals K. Nutrition management of patients with inherited disorders of aromatic amino acid metabolism. En: Acosta P. Nutrition Management of patients with inherited metabolic disorders, 1st edition, Sudbury MA: Jones and Bartlett Publisher; 2010. p. 119-74. | spa |
dc.rights.accessrights | info:eu-repo/semantics/openAccess | spa |
dc.type.coar | http://purl.org/coar/resource_type/c_6501 | spa |
dc.type.content | Text | spa |
dc.type.driver | info:eu-repo/semantics/article | spa |
dc.type.local | Journal article | eng |